Decibel Therapeutics

Decibel Therapeutics was founded in 2015 by leading world experts in the field of otology, with the mission to protect, repair and restore hearing. Decibel Therapeutics is targeting Drug-Induced Ototoxicity, Tinnitus, Noise-Induced Hearing Loss, Genetic Hearing Loss, as well as Presbycusis.

Clinical trials to be announced.

RECENT NEWS ON DECIBEL THERAPEUTICS

Nothing Found

Sorry, no posts matched your criteria

COMPANY OVERVIEW

Decibel Therapeutics

Locations: United States
Year Founded: 2015
CEO: Steven H. Holtzman (Ph.D.)